Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation

被引:15
作者
Riwes, Mary M. [1 ]
Golob, Jonathan L. [2 ]
Magenau, John [1 ]
Shan, Mengrou [3 ]
Dick, Gregory [4 ]
Braun, Thomas [5 ]
Schmidt, Thomas M. [2 ]
Pawarode, Attaphol [1 ]
Anand, Sarah [1 ]
Ghosh, Monalisa [1 ]
Maciejewski, John [1 ]
King, Darren [1 ]
Choi, Sung [1 ]
Yanik, Gregory [1 ]
Geer, Marcus [1 ]
Hillman, Ethan [2 ]
Lyssiotis, Costas A. [3 ]
Tewari, Muneesh [1 ]
Reddy, Pavan [1 ,6 ]
机构
[1] Univ Michigan, Rogel Canc Ctr, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA
[3] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI USA
[4] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI USA
[5] Univ Michigan, Dept Biostat, Ann Arbor, MI USA
[6] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA
关键词
VERSUS-HOST-DISEASE; CHAIN FATTY-ACIDS; EXPRESSION; DIVERSITY; BUTYRATE; GVHD; PROBIOTICS; PREBIOTICS; DAMAGE;
D O I
10.1038/s41591-023-02587-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evaluation of the impact of dietary intervention on gastrointestinal microbiota and metabolites after allogeneic hematopoietic stem cell transplantation (HCT) is lacking. We conducted a feasibility study as the first of a two-phase trial. Ten adults received resistant potato starch (RPS) daily from day -7 to day 100. The primary objective was to test the feasibility of RPS and its effect on intestinal microbiome and metabolites, including the short-chain fatty acid butyrate. Feasibility met the preset goal of 60% or more, adhering to 70% or more doses; fecal butyrate levels were significantly higher when participants were on RPS than when they were not (P < 0.0001). An exploratory objective was to evaluate plasma metabolites. We observed longitudinal changes in plasma metabolites compared to baseline, which were independent of RPS (P < 0.0001). However, in recipients of RPS, the dominant plasma metabolites were more stable compared to historical controls with significant difference at engraftment (P < 0.05). These results indicate that RPS in recipients of allogeneic HCT is feasible; in this study, it was associated with significant alterations in intestinal and plasma metabolites. A phase 2 trial examining the effect of RPS on graft-versus-host disease in recipients of allogeneic HCT is underway.
引用
收藏
页码:2805 / 2813
页数:16
相关论文
共 47 条
[1]   A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial [J].
Andermann, Tessa M. ;
Fouladi, Farnaz ;
Tamburini, Fiona B. ;
Sahaf, Bita ;
Tkachenko, Ekaterina ;
Greene, Courtney ;
Buckley, Matthew T. ;
Brooks, Erin F. ;
Hedlin, Haley ;
Arai, Sally ;
Mackall, Crystal L. ;
Miklos, David ;
Negrin, Robert S. ;
Fodor, Anthony A. ;
Rezvani, Andrew R. ;
Bhatt, Ami S. .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11) :932.e1-932.e11
[2]   The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future [J].
Andermann, Tessa M. ;
Peled, Jonathan U. ;
Ho, Christine ;
Reddy, Pavan ;
Riches, Marcie ;
Storb, Rainer ;
Teshima, Takanori ;
van den Brink, Marcel R. M. ;
Alousi, Amin ;
Balderman, Sophia ;
Chiusolo, Patrizia ;
Clark, William B. ;
Holler, Ernst ;
Howard, Alan ;
Kean, Leslie S. ;
Koh, Andrew Y. ;
McCarthy, Philip L. ;
McCarty, John M. ;
Mohty, Mohamad ;
Nakamura, Ryotaro ;
Rezvani, Katy ;
Segal, Brahm H. ;
Shaw, Bronwen E. ;
Shpall, Elizabeth J. ;
Sung, Anthony D. ;
Weber, Daniela ;
Whangbo, Jennifer ;
Wingard, John R. ;
Wood, William A. ;
Perales, Miguel-Angel ;
Jenq, Robert R. ;
Bhatt, Ami S. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) :1322-1340
[3]   Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation [J].
Andermann, Tessa M. ;
Rezvani, Andrew ;
Bhatt, Ami S. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (01) :19-28
[4]   Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[5]   Host-bacterial mutualism in the human intestine [J].
Bäckhed, F ;
Ley, RE ;
Sonnenburg, JL ;
Peterson, DA ;
Gordon, JI .
SCIENCE, 2005, 307 (5717) :1915-1920
[6]  
Baxter NT, 2019, MBIO, V10, DOI [10.1128/mBio.02566-18, 10.1128/mbio.02566-18]
[7]   Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin [J].
Casellas, F. ;
Borruel, N. ;
Torrejon, A. ;
Varela, E. ;
Antolin, M. ;
Guarner, F. ;
Malagelada, J. -R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) :1061-1067
[8]   Current and emerging strategies for the prevention of graft-versus-host disease [J].
Choi, Sung Won ;
Reddy, Pavan .
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) :536-547
[9]   Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant [J].
DeFilipp, Zachariah ;
Bloom, Patricia P. ;
Soto, Mariam Torres ;
Mansour, Michael K. ;
Sater, Mohamad R. A. ;
Huntley, Miriam H. ;
Turbett, Sarah ;
Chung, Raymond T. ;
Chen, Yi-Bin ;
Hohmann, Elizabeth L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :2043-2050
[10]   Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity [J].
DeFilipp, Zechariah ;
Peled, Jonathan U. ;
Li, Shuli ;
Mahabamunuge, Jasmin ;
Dagher, Zeina ;
Slingerland, Ann E. ;
Del Rio, Candice ;
Valles, Betsy ;
Kempner, Maria E. ;
Smith, Melissa ;
Brown, Jami ;
Dey, Bimalangshu R. ;
El-Jawahri, Areej ;
McAfee, Steven L. ;
Spitzer, Thomas R. ;
Ballen, Karen K. ;
Sung, Anthony D. ;
Dalton, Tara E. ;
Messina, Julia A. ;
Dettmer, Katja ;
Liebisch, Gerhard ;
Oefner, Peter ;
Taur, Ying ;
Pamer, Eric G. ;
Holler, Ernst ;
Mansour, Michael K. ;
van den Brink, Marcel R. M. ;
Hohmann, Elizabeth ;
Jenq, Robert R. ;
Chen, Yi-Bin .
BLOOD ADVANCES, 2018, 2 (07) :745-753